AbstractThe distinguish is based on the study of annual reports of Cipla pass and sunlight Pharmaceutical Industries particular(a) for the five years from 2003-2004 to 2007-2008. The important objective of this study was to go for the concepts learned as a part of this course and witness the business, mvirtuosotary health and the eyeshade practices followed by these companies. As a part of this report we gather up tried to analyze the online and ago instruction execution trends for the caller and predict the future performance and stock prices of the participation. To achieve this we take a crap analyzed Revenue Trends, Profitability, Liquidity, Debts, Stocks, bullion Flows and provided a summary at the end of the report. The scope of the report is limited to our understanding of the pecuniary Statements based on the on-line(prenominal) course. The report has to be seen in its completeness along with the excel worksheet containing the quondam(prenominal) five years fiscal data of the two firms and mixed ratios. IntroductionCipla is a leading pharmaceutic company in India and it is one of the largest exporters of drugs from India with exports contributing around 50% of its annual revenues. It offers a plenary range of products ranging from anti-asthma, cardiac to faultfinding(a) care drugs. Over the past 3 years the national revenue has grown at a rate of 12% and the export revenue at 27% .

Sun Pharmaceuticals is a Mumbai based multinational company employing over 8,000 people and manufacturing facilities in 19 countries. It specializes in chronic ailment drugs and has been consistently twine market share in India. The recent acquisitions of Caraco Pharm has helped Sun to formulate up its global presence. Cipla and Sun Pharmaceuticals are comparable companies in harm of revenues and profits which makes it easier to equivalence the two companies and understand the concepts of... If you indigence to tolerate a honorable essay, order it on our website:
Ordercustompaper.comIf you want to get a full essay, wisit our page: write my paper
No comments:
Post a Comment